title: Pharmacological update on new infusion drugs.
abstract: Ongoing clinical research and development of new infusion medications can challenge the infusion specialist's knowledge base in daily practice. This article reviews new and soon-to-be marketed infusion drugs, with an emphasis on biopharmaceuticals. The author also discusses mechanisms of action, drug interactions, side effects, and infusion specialist interventions for safe administration of these medications.
authors.affiliation: Home Infusion Service at Stanford University Medical Center, USA. glwilder@aol.com
authors.forename: G L
authors.initials: GL
authors.lastname: Wilder
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D001682:Biological Availability; D001702:Biopharmaceutics; D001709:Biotechnology / Q000639:trends; D000077336:Caspofungin; D054714:Echinocandins; D006207:Half-Life; D006801:Humans; D007262:Infusions, Intravenous; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D000970:Antineoplastic Agents; D054714:Echinocandins; D055666:Lipopeptides; D010455:Peptides; D010456:Peptides, Cyclic; D000077336:Caspofungin